Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Federal Whistleblower Files Constitutional Challenge to Private Equity HIG Capital Controlled Bankruptcy in Wellpath Holdings Case





Dr. Kanwar P. S. Gill, M.D., submits 75-in-One Verified Emergency Motion Suite alleging procedural sabotage, non-consensual third-party releases, and systemic ADA, ERISA, and fiduciary breaches in Case No. 24-90533 (SDTX).

Federal Whistleblower Files 75-in-One Motion Suite in Wellpath–H.I.G. Bankruptcy, Citing Suppression, ADA Retaliation, and Procedural Fraud

FRESNO, CA, April 29, 2025 /24-7PressRelease/ -- Dr. Kanwar Partap Singh Gill, M.D., a board-certified California physician and federally protected whistleblower, has filed the 75-in-One Verified Emergency Motion Suite in the bankruptcy proceedings of Wellpath Holdings, Inc. (Case No. 24-90533, SDTX). This unprecedented 300-page emergency filing constitutes the most comprehensive verified whistleblower submission in the history of the federal bankruptcy system.

The motion suite challenges what Dr. Gill alleges is a procedurally and constitutionally tainted reorganization process, orchestrated by private equity sponsor H.I.G. Capital and its agents. According to the filing, the bankruptcy was not a good-faith debt restructuring, but rather a mechanism to extinguish billions in legal exposure through the abuse of non-consensual third-party releases, ballot manipulation, and judicial docket suppression.

Between April 14 and April 22, 2025, Dr. Gill submitted eight verified filings—raising formal objections to the plan, asserting ADA retaliation, ERISA fiduciary breaches, IRS §409A noncompliance, and governance-based CPOM violations. However, none were publicly docketed. The plan and solicitation proceeded without record of those objections, giving the false impression of creditor consensus.

In response, Dr. Gill filed the 75-in-One Verified Emergency Motion Suite, which includes motions to:

Strike Dkt. 2321 (Plan Supplement),

Invalidate tainted ballots and voting reports,

Disqualify noticing agent Epiq and debtor counsel McDermott Will & Emery LLP,

Enforce constitutional due process rights under the Fifth Amendment,

Trigger DOJ, U.S. Trustee, and Grand Jury referrals under 18 U.S.C. §§ 371, 1519, 3332.

The filing invokes statutory protections under the Americans with Disabilities Act (ADA), ERISA, CPOM Doctrine, and governing bankruptcy statutes including 11 U.S.C. §§ 105(a), 1125(b), 1129(a), and Rule 60(d)(3).

A confirmation hearing is scheduled for April 30, 2025, in the U.S. Bankruptcy Court for the Southern District of Texas, Houston Division. Dr. Gill asserts that confirmation cannot lawfully proceed while 75 verified motions are pending, and has declared his intent to pursue post-confirmation remedies through Rule 60 relief, appellate review, and federal prosecution.

About Dr. Kanwar Partap Singh Gill, M.D.
Dr. Kanwar Partap Singh Gill, M.D., is a board-certified physician, federal whistleblower, and verified statutory creditor based in Fresno, California. With over 15 years of clinical leadership and public advocacy experience, Dr. Gill has consistently championed healthcare integrity, disability rights, fiduciary accountability, and constitutional protections within judicial systems.

In the matter of In re Wellpath Holdings, Inc., Case No. 24-90533 (SDTX), Dr. Gill serves as the sole verified pro se objector, advancing a comprehensive constitutional and statutory challenge to procedural irregularities affecting ADA, ERISA, and creditor due process rights. His verified filings—including the historic 75-in-One Verified Emergency Motion Suite—reflect an unwavering commitment to exposing structural abuse, protecting whistleblower rights, and upholding the foundational principles of equitable judicial administration.

Dr. Gill's work represents a rare and uncompromising defense of constitutional governance in the face of coordinated private equity influence within federal bankruptcy proceedings.

Media Contact
Dr. Kanwar Partap Singh Gill, M.D.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.